Refine Search
(2)
(3)
(19)
(23)

Osteoarthritis - Pipeline Review, H1 2019

  • $2,000
  • April 2019
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Osteoarthritis - Pipeline Review, H1 2019’, provides an overview of the Osteoarthritis pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Osteoarthritis, ...

Sarcopenia - Pipeline Review, H1 2019

  • $2,000
  • February 2019
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Sarcopenia - Pipeline Review, H1 2019’, provides an overview of the Sarcopenia pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Sarcopenia, complete wit...

Degenerative Disc Disease - Pipeline Review, H1 2019

  • $2,000
  • January 2019
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Degenerative Disc Disease - Pipeline Review, H1 2019’, provides an overview of the Degenerative Disc Disease pipeline landscape.

The report provides comprehensive information on the therapeutics under developmen...

Inclusion Body Myositis (IBM) - Pipeline Review, H2 2018

  • $2,000
  • October 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Inclusion Body Myositis (IBM) - Pipeline Review, H2 2018’, provides an overview of the Inclusion Body Myositis (IBM) pipeline landscape.

The report provides comprehensive information on the therapeutics under de...

Muscle Atrophy - Pipeline Review, H2 2018

  • $2,000
  • September 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Muscle Atrophy - Pipeline Review, H2 2018’, provides an overview of the Muscle Atrophy pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Muscle Atrophy, ...

Achondroplasia - Pipeline Review, H2 2018

  • $2,000
  • September 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Achondroplasia - Pipeline Review, H2 2018’, provides an overview of the Achondroplasia pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Achondroplasia, ...

Bone Fracture - Pipeline Review, H2 2018

  • $2,000
  • September 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Bone Fracture - Pipeline Review, H2 2018’, provides an overview of the Bone Fracture pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Bone Fracture, com...

Systemic Idiopathic Juvenile Arthritis - Pipeline Review, H2 2018

  • $2,000
  • September 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Systemic Idiopathic Juvenile Arthritis - Pipeline Review, H2 2018’, provides an overview of the Systemic Idiopathic Juvenile Arthritis pipeline landscape.

The report provides comprehensive information on the the...

Prosthetic joint infections - Pipeline Review, H1 2018

  • $2,000
  • June 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Prosthetic joint infections - Pipeline Review, H1 2018’, provides an overview of the Prosthetic joint infections pipeline landscape.

The report provides comprehensive information on the therapeutics under develo...

Fibrodysplasia Ossificans Progressiva (Myositis Ossificans Progressiva) - Pipeline Review, H1 2018

  • $2,000
  • June 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Fibrodysplasia Ossificans Progressiva (Myositis Ossificans Progressiva) - Pipeline Review, H1 2018’, provides an overview of the Fibrodysplasia Ossificans Progressiva (Myositis Ossificans Progressiva) pipeline landscap...

Psoriatic Arthritis - Pipeline Review, H1 2018

  • $2,000
  • May 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Psoriatic Arthritis - Pipeline Review, H1 2018’, provides an overview of the Psoriatic Arthritis pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Psoria...

Axial Spondyloarthritis - Pipeline Review, H1 2018

  • $2,000
  • May 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Axial Spondyloarthritis - Pipeline Review, H1 2018’, provides an overview of the Axial Spondyloarthritis pipeline landscape.

The report provides comprehensive information on the therapeutics under development fo...

Gouty Arthritis (Gout) - Pipeline Review, H1 2018

  • $2,000
  • May 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Gouty Arthritis (Gout) - Pipeline Review, H1 2018’, provides an overview of the Gouty Arthritis (Gout) pipeline landscape.

The report provides comprehensive information on the therapeutics under development for ...

Pigmented Villonodular Synovitis - Pipeline Review, H1 2018

  • $2,000
  • May 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Pigmented Villonodular Synovitis - Pipeline Review, H1 2018’, provides an overview of the Pigmented Villonodular Synovitis pipeline landscape.

The report provides comprehensive information on the therapeutics un...

Muscular Dystrophy - Pipeline Review, H1 2018

  • $2,000
  • May 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Muscular Dystrophy - Pipeline Review, H1 2018’, provides an overview of the Muscular Dystrophy pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Muscular...

Osteonecrosis - Pipeline Review, H1 2018

  • $2,000
  • May 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Osteonecrosis - Pipeline Review, H1 2018’, provides an overview of the Osteonecrosis pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Osteonecrosis, com...

Ankylosing Spondylitis (Bekhterev's Disease) - Pipeline Review, H1 2018

  • $2,000
  • May 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Ankylosing Spondylitis (Bekhterev's Disease) - Pipeline Review, H1 2018’, provides an overview of the Ankylosing Spondylitis (Bekhterev's Disease) pipeline landscape.

The report provides comprehensive in...

Dermatomyositis - Pipeline Review, H1 2018

  • $2,000
  • May 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Dermatomyositis - Pipeline Review, H1 2018’, provides an overview of the Dermatomyositis pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Dermatomyositi...

Polyarticular Juvenile Idiopathic Arthritis (PJIA) - Pipeline Review, H1 2018

  • $2,000
  • May 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Polyarticular Juvenile Idiopathic Arthritis (PJIA) - Pipeline Review, H1 2018’, provides an overview of the Polyarticular Juvenile Idiopathic Arthritis (PJIA) pipeline landscape.

The report provides comprehensiv...

Thrombotic Thrombocytopenic Purpura - Pipeline Review, H1 2018

  • $2,000
  • April 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Thrombotic Thrombocytopenic Purpura - Pipeline Review, H1 2018’, provides an overview of the Thrombotic Thrombocytopenic Purpura pipeline landscape.

The report provides comprehensive information on the therapeut...

Dupuytren Contracture - Pipeline Review, H2 2017

  • $2,000
  • September 2017
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Dupuytren Contracture - Pipeline Review, H2 2017’, provides an overview of the Dupuytren Contracture pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Du...

Fibrosis - Pipeline Review, H2 2017

  • $2,000
  • September 2017
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Fibrosis - Pipeline Review, H2 2017’, provides an overview of the Fibrosis pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Fibrosis, complete with anal...

Cachexia - Pipeline Review, H2 2017

  • $2,000
  • September 2017
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Cachexia - Pipeline Review, H2 2017’, provides an overview of the Cachexia pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Cachexia, complete with anal...

Myotonic Dystrophy - Pipeline Review, H2 2016

  • $2,000
  • July 2016
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Myotonic Dystrophy - Pipeline Review, H2 2016’, provides an overview of the Myotonic Dystrophy pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Myotonic...

Cancer Cachexia - Pipeline Review, H2 2016

  • $2,000
  • July 2016
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Cancer Cachexia - Pipeline Review, H2 2016’, provides an overview of the Cancer Cachexia pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Cancer Cachexi...